U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 71

1.
Ductal carcinoma in-situ arising within benign phyllodes tumours
S-A Lui, HB Oh, S Wang, CW Chan
Ann R Coll Surg Engl. 2018 Apr; 100(4): e97–e102. Published online 2018 Feb 27. doi: 10.1308/rcsann.2018.0024
PMCID:
PMC5958862
AbstractArticlePDF–1.4M
2.
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors
Andi K. Cani, Daniel H. Hovelson, Andrew S. McDaniel, Seth Sadis, Michaela J. Haller, Venkata Yadati, Anmol M. Amin, Jarred Bratley, Santhoshi Bandla, Paul D. Williams, Kate Rhodes, Chia-Jen Liu, Michael J. Quist, Daniel R. Rhodes, Catherine S. Grasso, Celina G. Kleer, Scott A. Tomlins
Mol Cancer Res. Author manuscript; available in PMC 2016 Jul 7.
Published in final edited form as: Mol Cancer Res. 2015 Apr; 13(4): 613–619. Published online 2015 Jan 15. doi: 10.1158/1541-7786.MCR-14-0578
PMCID:
PMC4936398
AbstractArticlePDF–939K
3.
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression
Salvatore Piscuoglio, Charlotte K Y Ng, Melissa Murray, Kathleen A Burke, Marcia Edelweiss, Felipe C Geyer, Gabriel S Macedo, Akiko Inagaki, Anastasios D Papanastasiou, Luciano G Martelotto, Caterina Marchio, Raymond S Lim, Rafael A Ioris, Pooja K Nahar, Ino De Bruijn, Lillian Smyth, Muzaffar Akram, Dara Ross, John H Petrini, Larry Norton, David B Solit, Jose Baselga, Edi Brogi, Marc Ladanyi, Britta Weigelt, Jorge S Reis-Filho
J Pathol. Author manuscript; available in PMC 2017 Mar 1.
Published in final edited form as: J Pathol. 2016 Mar; 238(4): 508–518. Published online 2016 Jan 25. doi: 10.1002/path.4672
PMCID:
PMC4962788
AbstractArticlePDF–624K
4.
Uterine adenosarcomas are mesenchymal neoplasms
Salvatore Piscuoglio, Kathleen A Burke, Charlotte KY Ng, Anastasios D Papanastasiou, Felipe C Geyer, Gabriel S Macedo, Luciano G Martelotto, Ino de Bruijn, Maria R De Filippo, Anne M Schultheis, Rafael A Ioris, Douglas A Levine, Robert A Soslow, Brian P Rubin, Jorge S Reis-Filho, Britta Weigelt
J Pathol. Author manuscript; available in PMC 2017 Feb 1.
Published in final edited form as: J Pathol. 2016 Feb; 238(3): 381–388. Published online 2015 Dec 28. doi: 10.1002/path.4675
PMCID:
PMC4986517
AbstractArticlePDF–2.0M
5.
MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways
Marick Laé, Sophie Gardrat, Sophie Rondeau, Camille Richardot, Martial Caly, Walid Chemlali, Sophie Vacher, Jérôme Couturier, Odette Mariani, Philippe Terrier, Ivan Bièche
Oncotarget. 2016 Dec 20; 7(51): 84428–84438. Published online 2016 Oct 31. doi: 10.18632/oncotarget.12991
PMCID:
PMC5356671
AbstractArticlePDF–1.4M
6.
Phyllodes tumors of the breast in 2 sisters: Case report and review of literature
Yichao Wang, Jingqiang Zhu, Junhe Gou, JunJie Xiong, Xiaoqin Yang
Medicine (Baltimore) 2017 Nov; 96(46): e8552. Published online 2017 Nov 17. doi: 10.1097/MD.0000000000008552
PMCID:
PMC5704806
AbstractArticlePDF–528K
7.
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
Jan Budczies, Carsten Denkert, Balázs Győrffy, Peter Schirmacher, Albrecht Stenzinger
BMC Med Genomics. 2017; 10: 74. Published online 2017 Dec 6. doi: 10.1186/s12920-017-0308-8
PMCID:
PMC5719741
AbstractArticlePDF–1.8M
8.
MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours
Diego A Garcia-Dios, Dina Levi, Vandna Shah, Cheryl Gillett, Michael A Simpson, Andrew Hanby, Ian Tomlinson, Elinor J Sawyer
Br J Cancer. 2018 Jan; 118(2): 277–284. Published online 2018 Jan 9. doi: 10.1038/bjc.2017.450
PMCID:
PMC5785756
AbstractArticlePDF–783K
9.
Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast
Julia Y. S. Tsang, Yau-Kam Hui, Michelle A. Lee, Maribel Lacambra, Yun-Bi Ni, Sai-Yin Cheung, Cherry Wu, Ava Kwong, Gary M. K. Tse
Sci Rep. 2018; 8: 3881. Published online 2018 Mar 1. doi: 10.1038/s41598-018-22232-w
PMCID:
PMC5832760
AbstractArticlePDF–1.1M
10.
Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases with Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations
Shih-Chiang Huang, Lei Zhang, Yun-Shao Sung, Chun-Liang Chen, Yu-Chien Kao, Narasimhan P Agaram, Samuel Singer, William D Tap, Sandra D’Angelo, Cristina R Antonescu
Am J Surg Pathol. Author manuscript; available in PMC 2017 May 1.
Published in final edited form as: Am J Surg Pathol. 2016 May; 40(5): 645–655. doi: 10.1097/PAS.0000000000000582
PMCID:
PMC4833528
AbstractArticlePDF–2.2M
11.
Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms
Adam Stenman, Jan Zedenius, Carl Christofer Juhlin
Langenbecks Arch Surg. 2018; 403(6): 785–790. Published online 2018 May 19. doi: 10.1007/s00423-018-1679-9
PMCID:
PMC6153590
AbstractArticlePDF–929K
12.
Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults
Fresia Pareja, Arnaud Da Cruz Paula, Melissa P. Murray, Timothy Hoang, Rodrigo Gularte-Merida, David Brown, Edaise M. da Silva, Ana Paula Martins Sebastião, Dilip D. Giri, Britta Weigelt, Jorge S. Reis-Filho, Edi Brogi
J Clin Pathol. Author manuscript; available in PMC 2019 Jun 18.
Published in final edited form as: J Clin Pathol. 2019 Mar; 72(3): 258–262. Published online 2018 Nov 22. doi: 10.1136/jclinpath-2018-205570
PMCID:
PMC6580856
AbstractArticlePDF–1.1M
13.
Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open‐label phase 2 trial
Kenji Tamura, Kosei Hasegawa, Noriyuki Katsumata, Koji Matsumoto, Hirofumi Mukai, Shunji Takahashi, Hiroyuki Nomura, Hironobu Minami
Cancer Sci. 2019 Sep; 110(9): 2894–2904. Published online 2019 Sep 3. doi: 10.1111/cas.14148
PMCID:
PMC6726684
AbstractArticlePDF–735K
14.
Comparative genomics reveals shared mutational landscape in canine hemangiosarcoma and human angiosarcoma
Kate Megquier, Jason Turner-Maier, Ross Swofford, Jong-Hyuk Kim, Aaron L. Sarver, Chao Wang, Sharadha Sakthikumar, Jeremy Johnson, Michele Koltookian, Mitzi Lewellen, Milcah C. Scott, Ashley J. Schulte, Luke Borst, Noriko Tonomura, Jessica Alfoldi, Corrie Painter, Rachael Thomas, Elinor K. Karlsson, Matthew Breen, Jaime F. Modiano, Ingegerd Elvers, Kerstin Lindblad-Toh
Mol Cancer Res. Author manuscript; available in PMC 2020 Jun 1.
Published in final edited form as: Mol Cancer Res. 2019 Dec; 17(12): 2410–2421. Published online 2019 Sep 30. doi: 10.1158/1541-7786.MCR-19-0221
PMCID:
PMC7067513
AbstractArticlePDF–932K
15.
Frequency of radiation-induced malignancies post–adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome
Anh N. Le, Joanna Harton, Heena Desai, Jacquelyn Powers, Kristin Zelley, Angela Bradbury, Katherine Nathanson, Payal D. Shah, Abigail Doucette, Gary Freedman, Peter Gabriel, Susan M. Domchek, Suzanne P. MacFarland, Kara N. Maxwell
Breast Cancer Res Treat. Author manuscript; available in PMC 2021 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2020 May; 181(1): 181–188. Published online 2020 Apr 3. doi: 10.1007/s10549-020-05612-7
PMCID:
PMC7285877
AbstractArticlePDF–344K
16.
Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence
Sha Zhang, Liang Yan, Can Cui, Zhen Wang, Jianhui Wu, Min Zhao, Bin Dong, Xiaoya Guan, Xiuyun Tian, Chunyi Hao
Oncol Rep. 2020 Aug; 44(2): 565–576. Published online 2020 Jun 5. doi: 10.3892/or.2020.7635
PMCID:
PMC7336505
AbstractArticlePDF–1.5M
17.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study
Annika Fendler, Scott T.C. Shepherd, Lewis Au, Katalin A. Wilkinson, Mary Wu, Fiona Byrne, Maddalena Cerrone, Andreas M. Schmitt, Nalinie Joharatnam-Hogan, Benjamin Shum, Zayd Tippu, Karolina Rzeniewicz, Laura Amanda Boos, Ruth Harvey, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, Sarah Sarker, Karla Lingard, Mary Mangwende, Lucy Holt, Hamid Ahmod, Justine Korteweg, Tara Foley, Jessica Bazin, William Gordon, Taja Barber, Andrea Emslie-Henry, Wenyi Xie, Camille L. Gerard, Daqi Deng, Emma C. Wall, Ana Agua-Doce, Sina Namjou, Simon Caidan, Mike Gavrielides, James I MacRae, Gavin Kelly, Kema Peat, Denise Kelly, Aida Murra, Kayleigh Kelly, Molly O’Flaherty, Lauren Dowdie, Natalie Ash, Firza Gronthoud, Robyn L. Shea, Gail Gardner, Darren Murray, Fiona Kinnaird, Wanyuan Cui, Javier Pascual, Simon Rodney, Justin Mencel, Olivia Curtis, Clemency Stephenson, Anna Robinson, Bhavna Oza, Sheima Farag, Isla Leslie, Aljosja Rogiers, Sunil Iyengar, Mark Ethell, Christina Messiou, David Cunningham, Ian Chau, Naureen Starling, Nicholas Turner, Liam Welsh, Nicholas van As, Robin L. Jones, Joanne Droney, Susana Banerjee, Kate C. Tatham, Mary O’Brien, Kevin Harrington, Shreerang Bhide, Alicia Okines, Alison Reid, Kate Young, Andrew J.S. Furness, Lisa Pickering, Charles Swanton, on behalf of the Crick COVID19 consortium, Sonia Gandhi, Steve Gamblin, David LV Bauer, George Kassiotis, Sacheen Kumar, Nadia Yousaf, Shaman Jhanji, Emma Nicholson, Michael Howell, Susanna Walker, Robert J. Wilkinson, James Larkin, Samra Turajlic
Nat Cancer. Author manuscript; available in PMC 2021 Dec 22.
Published in final edited form as: Nat Cancer. 2021 Dec; 2: 1321–1337. Published online 2021 Oct 27. doi: 10.1038/s43018-021-00274-w
PMCID:
PMC7612125
AbstractArticlePDF–4.1M
18.
Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair–Deficient Uterine Leiomyosarcoma
Horace H.Y. Lee, Kin Long Chow, Ho Shing Wong, Tsz Yan Chong, Alice S.T. Wong, Grace H.W. Cheng, Jasmine M.K. Ko, Hoi Cheong Siu, Maximus C.F. Yeung, Michael S.Y. Huen, Ka Yu Tse, Mark R. Bray, Tak Wah Mak, Suet Yi Leung, Philip P.C. Ip
Clin Cancer Res. 2024 Sep 3; 30(17): 3904–3918. Published online 2024 Jun 7. doi: 10.1158/1078-0432.CCR-23-3720
PMCID:
PMC11369621
AbstractArticlePDF–8.0M
19.
Frequent MED12 mutations in phyllodes tumours of the breast
M Yoshida, S Sekine, R Ogawa, H Yoshida, A Maeshima, Y Kanai, T Kinoshita, A Ochiai
Br J Cancer. 2015 May 12; 112(10): 1703–1708. Published online 2015 Apr 2. doi: 10.1038/bjc.2015.116
PMCID:
PMC4430713
AbstractArticlePDF–1.3M
20.
Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.
A. Forus, J. M. Berner, L. A. Meza-Zepeda, G. Saeter, D. Mischke, O. Fodstad, O. Myklebost
Br J Cancer. 1998 Aug; 78(4): 495–503. doi: 10.1038/bjc.1998.521
PMCID:
PMC2063085
SummaryPage BrowsePDF–2.3M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center